CDC/FDA Public Online Workshop: Drug Development Considerations for the Prevention of HealthCare-Associated Infections

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are announcing the following public virtual workshop entitled ‘Drug Development Considerations for the Prevention of HealthCare-Associated Infections’.

Date: August 30, 2022

Time: 8:30 a.m. – 5 p.m. EDT

DESCRIPTION AND SUMMARY
Discussions are planned around the following topics/areas:

• The current state of development of pathogen-directed products used to prevent healthcare-associated infections
• Evidence supporting decolonization and pathogen reduction (in colonized patients) as a strategy to prevent infection and transmission of antimicrobial-resistant healthcare-associated pathogens
• Antimicrobial resistance threats as potential targets for decolonization and pathogen reduction
• Challenges and potential approaches to drug development and registration of products for the prevention of healthcare-associated infections

Registration link here

All meeting materials—including agenda, panelist affiliations/disclosures, speaker slides, workshop recording, and transcript—will be posted here shortly before and/or after the completion of the workshop.